Category: Press Releases

A new manuscript by Friends of Cancer Research (Friends) published today in AACR’s Clinical Cancer Research, shows that a substantial number of oncology drugs undergo additional dose evaluation after approval through Postmarketing Requirements (PMRs), studies that sponsors are required to conduct after approval to gather additional information about a product’s safety and/or efficacy. These findings…

Friends of Cancer Research (Friends) applauds President Biden for nominating Dr. W. Kimryn Rathmell as Director of the National Cancer Institute (NCI) and extends our deepest gratitude to recently confirmed Director of the National Institutes of Health, Dr. Monica Bertagnolli, for her steadfast leadership as Director of the NCI. “Dr. Rathmell brings extensive scientific expertise…

FDA Commissioner Califf to Receive the Ellen V. Sigal Advocacy Leadership Award Congresswoman Dingell to Receive the Marlene A. Malek Public Service Award Washington, DC – August 15, 2023 – Friends of Cancer Research (Friends) is proud to announce our 2023 Cancer Leadership Awards honorees: Commissioner of the U.S. Food and Drug Administration, Dr. Robert Califf,…

Friends of Cancer Research (Friends) is excited to present data from three current projects at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These findings are catalyzing meaningful improvements in oncology drug development and informing regulatory policy and patient care. Abstract Details  Changes in ctDNA levels as an early indicator of outcomes in…

Friends of Cancer Research (Friends) thanks President Joe Biden for nominating Dr. Monica Bertagnolli as the Director of the National Institute of Health (NIH). “At this critical time for innovation at the NIH, Dr. Bertagnolli will be the visionary leader we need,” said Ellen Sigal, Chair & Founder of Friends of Cancer Research.  As the…

Friends of Cancer Research (Friends) commends the National Cancer Institute (NCI) and their Director Dr. Monica Bertagnolli, for the recently announced National Cancer Plan. This critical and innovative plan provides a framework for collaboration and partnership across agencies seeking to improve the lives of millions of cancer patients and families.  “Dr. Bertagnolli and the Biden…

Friends of Cancer Research (Friends) applauds Larry Bucshon (R-IN) and Diana DeGette (D-CO) for their leadership introducing the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act).  The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play a critical role in patient care.…

Friends of Cancer Research (Friends) is excited to announce the addition of City of Hope physician executive Edward S. Kim, M.D., M.B.A., FACP, FASCO, to its Board of Directors. Dr. Kim, recognized as one of the top cancer experts in the nation, is Physician-in-Chief and Senior Vice President, City of Hope Orange County, Construction Industries Alliance…

A new manuscript by Friends of Cancer Research (Friends) published today in JCO Clinical Cancer Informatics, details a framework to align electronic patient reported outcome (ePRO) data capture across ePRO tools to assess the value of ePROs for improving patient outcomes. This work can help expedite efforts to generate robust real-world data (RWD). PROs are…

Friends of Cancer Research (Friends) is pleased to support the most recent version of the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) and urges Congress to include this as part of the 2023 omnibus appropriations bill. The VALID Act would resolve longstanding uncertainty associated with the regulation and use of diagnostic tests that play…